Corcept Therapeutics' GAAP net income for the six months of 2021 was $49.988 million, down 14.4% from $58.392 million in the previous year. Revenue decreased 5.9% to $171.025 million from $181.812 million a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept